ATE481115T1 - Hämostatische vorrichtungen und zusammensetzungen aus oxidierter zellulosepartikel und ein polysaccharid bindemittel - Google Patents

Hämostatische vorrichtungen und zusammensetzungen aus oxidierter zellulosepartikel und ein polysaccharid bindemittel

Info

Publication number
ATE481115T1
ATE481115T1 AT04253808T AT04253808T ATE481115T1 AT E481115 T1 ATE481115 T1 AT E481115T1 AT 04253808 T AT04253808 T AT 04253808T AT 04253808 T AT04253808 T AT 04253808T AT E481115 T1 ATE481115 T1 AT E481115T1
Authority
AT
Austria
Prior art keywords
compositions
oxidized cellulose
cellulose particles
hemostatic devices
polysaccharide binder
Prior art date
Application number
AT04253808T
Other languages
English (en)
Inventor
Dwayne Lee Looney
Kenneth Troger
Bruce Lamb
Benjamin Walthall
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Application granted granted Critical
Publication of ATE481115T1 publication Critical patent/ATE481115T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0095—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT04253808T 2003-06-25 2004-06-25 Hämostatische vorrichtungen und zusammensetzungen aus oxidierter zellulosepartikel und ein polysaccharid bindemittel ATE481115T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/603,320 US20040265371A1 (en) 2003-06-25 2003-06-25 Hemostatic devices and methods of making same

Publications (1)

Publication Number Publication Date
ATE481115T1 true ATE481115T1 (de) 2010-10-15

Family

ID=33435338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04253808T ATE481115T1 (de) 2003-06-25 2004-06-25 Hämostatische vorrichtungen und zusammensetzungen aus oxidierter zellulosepartikel und ein polysaccharid bindemittel

Country Status (7)

Country Link
US (2) US20040265371A1 (de)
EP (1) EP1493451B1 (de)
JP (1) JP4920177B2 (de)
CN (1) CN100384489C (de)
AT (1) ATE481115T1 (de)
DE (1) DE602004029118D1 (de)
ES (1) ES2349775T3 (de)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US7637948B2 (en) 1997-10-10 2009-12-29 Senorx, Inc. Tissue marking implant
US8361082B2 (en) 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US20090030309A1 (en) 2007-07-26 2009-01-29 Senorx, Inc. Deployment of polysaccharide markers
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US7651505B2 (en) 2002-06-17 2010-01-26 Senorx, Inc. Plugged tip delivery for marker placement
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US20080039819A1 (en) * 2006-08-04 2008-02-14 Senorx, Inc. Marker formed of starch or other suitable polysaccharide
US6725083B1 (en) 1999-02-02 2004-04-20 Senorx, Inc. Tissue site markers for in VIVO imaging
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
AU2002239290A1 (en) 2000-11-20 2002-06-03 Senorx, Inc. Tissue site markers for in vivo imaging
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US20050273002A1 (en) 2004-06-04 2005-12-08 Goosen Ryan L Multi-mode imaging marker
US9358318B2 (en) * 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
CA2584698C (en) 2004-10-20 2014-02-25 Ethicon, Inc. A reinforced absorbable multilayered hemostatic wound dressing and method of making
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
FR2889449B1 (fr) * 2005-08-05 2011-06-10 Khorionyx Preparations implantables
CA2562580C (en) 2005-10-07 2014-04-29 Inrad, Inc. Drug-eluting tissue marker
WO2008006083A2 (en) 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
ES2443526T3 (es) 2006-10-23 2014-02-19 C.R. Bard, Inc. Marcador mamario
US9579077B2 (en) 2006-12-12 2017-02-28 C.R. Bard, Inc. Multiple imaging mode tissue marker
US8401622B2 (en) 2006-12-18 2013-03-19 C. R. Bard, Inc. Biopsy marker with in situ-generated imaging properties
CN101121041A (zh) * 2007-08-09 2008-02-13 美国淀粉医疗公司 变性淀粉可吸收性止血材料及其制备方法
US20090062233A1 (en) 2007-08-09 2009-03-05 Xin Ji Modified starch material of biocompatible hemostasis
US8557874B2 (en) * 2007-11-26 2013-10-15 Epic Wound Care, Inc. Hemostatic material
US8158155B2 (en) * 2007-12-20 2012-04-17 Kimberly-Clark Worldwide, Inc. Odor control cellulose-based granules
WO2009099767A2 (en) 2008-01-31 2009-08-13 C.R. Bard, Inc. Biopsy tissue marker
CA2716010C (en) 2008-04-03 2019-10-01 Zymogenetics, Inc. Hemostatic microspheres
US9271706B2 (en) 2008-08-12 2016-03-01 Covidien Lp Medical device for wound closure and method of use
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
US9889230B2 (en) * 2008-10-17 2018-02-13 Covidien Lp Hemostatic implant
WO2010077244A1 (en) 2008-12-30 2010-07-08 C.R. Bard Inc. Marker delivery device for tissue marker placement
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
AU2010246025B2 (en) 2009-05-04 2015-11-12 Oregon Biomedical Engineering Institute, Inc. Hemorrhage control devices and methods
US9511167B2 (en) 2009-05-28 2016-12-06 Gp Cellulose Gmbh Modified cellulose from chemical kraft fiber and methods of making and using the same
BRPI1012052A2 (pt) 2009-05-28 2017-12-26 Gp Cellulose Gmbh fibras kraft hidrolisadas e quimicamente modificadas e métodos de produção e de branqueamento de fibras kraft
US9512237B2 (en) 2009-05-28 2016-12-06 Gp Cellulose Gmbh Method for inhibiting the growth of microbes with a modified cellulose fiber
US9512563B2 (en) 2009-05-28 2016-12-06 Gp Cellulose Gmbh Surface treated modified cellulose from chemical kraft fiber and methods of making and using same
US8470355B2 (en) * 2009-10-01 2013-06-25 Covidien Lp Mesh implant
WO2011090410A1 (en) * 2010-01-19 2011-07-28 Sca Hygiene Products Ab Absorbent article comprising an absorbent porous foam
US20120053619A1 (en) * 2010-08-31 2012-03-01 Boston Scientific Scimed, Inc. Hemostatic compositions and methods of making and using same
US9084602B2 (en) 2011-01-26 2015-07-21 Covidien Lp Buttress film with hemostatic action for surgical stapling apparatus
CA2827486A1 (en) 2011-02-16 2012-08-23 Andrew BAROFSKY Wound stasis dressing for large surface wounds
US9623223B2 (en) 2011-02-16 2017-04-18 Revmedx, Inc. Wound dressings comprising a plurality of liquid-expandable articles
CA2850486C (en) * 2011-09-29 2022-03-22 Polyganics B.V. Process for preparing a synthetic foam having a controlled particle distribution
US9028851B2 (en) * 2011-12-21 2015-05-12 Ethicon, Inc. Hemostatic materials and devices with galvanic particulates
US8815832B2 (en) * 2012-05-25 2014-08-26 Ethicon, Inc. Oxidized regenerated cellulose hemostatic powders and methods of making
JP6298468B2 (ja) 2012-10-16 2018-03-20 サーモディクス，インコーポレイテッド 創傷充填デバイスおよび方法
CN105143547B (zh) 2013-03-15 2018-05-01 Gp 纤维素股份有限公司 具有增高羧基含量的低粘度牛皮纸纤维及其制造和使用方法
USD716450S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715942S1 (en) 2013-09-24 2014-10-21 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD715442S1 (en) 2013-09-24 2014-10-14 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
USD716451S1 (en) 2013-09-24 2014-10-28 C. R. Bard, Inc. Tissue marker for intracorporeal site identification
WO2016011315A1 (en) * 2014-07-18 2016-01-21 Ethicon, Inc. Combination cellulose material and method of making and using same
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
CN104324408B (zh) * 2014-09-25 2016-05-18 沈丽青 复合生物止血修复医用胶冲洗液的处方及制备方法
US10184011B2 (en) 2014-10-31 2019-01-22 Core Scientific Creations Ltd. Hemostatic devices with improved properties and methods of making same
RU2017112748A (ru) 2014-11-17 2018-12-19 Арно Терапьютикс, Инк. Композиции онапристона пролонгированного действия и способы
US11382731B2 (en) 2015-02-27 2022-07-12 Covidien Lp Medical devices with sealing properties
CN107847635B (zh) 2015-05-06 2021-08-27 捷锐士阿希迈公司(以奥林巴斯美国外科技术名义) 羧甲基壳聚糖海绵制剂
WO2017030908A1 (en) 2015-08-14 2017-02-23 Ethicon, Inc. Method of treating a disease using a glycolytic dependent compound
CA2998924A1 (en) 2015-09-25 2017-03-30 Context Biopharma Inc. Methods of making onapristone intermediates
KR102688275B1 (ko) * 2015-11-06 2024-07-26 에디컨인코포레이티드 압밀된 지혈 셀룰로오스 집합체
KR102665892B1 (ko) 2015-11-08 2024-05-16 옴릭스 바이오파머슈티컬스 리미티드 셀룰로오스-기반의 짧은 섬유 및 긴 섬유의 지혈 혼합물
CA3008422A1 (en) 2015-12-15 2017-06-22 Context Biopharma Inc. Amorphous onapristone compositions and methods of making the same
EP3248578A1 (de) * 2016-05-24 2017-11-29 Biocer-Entwicklungs-GmbH Hämostaseeinheit und anordnung damit
CN107754005B (zh) * 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法
US11413335B2 (en) * 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
CN106421875B (zh) * 2016-11-15 2019-08-27 广州迈普再生医学科技股份有限公司 可降解吸收的止血纤维材料及其制备方法和止血纤维制品
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection
CN111587129A (zh) * 2018-01-12 2020-08-25 波士顿科学国际有限公司 实现止血的粉末
CN110732037B (zh) 2018-07-20 2023-05-26 广州倍绣生物技术有限公司 止血糊剂及其制备方法
IL262716A (en) 2018-11-01 2018-11-29 Omrix Biopharmaceuticals Ltd Oxidized cellulose preparations
IL268572A (en) 2019-08-07 2019-09-26 Omrix Biopharmaceuticals Ltd An expandable hemostatic composed of oxidized cellulose
KR102886728B1 (ko) 2019-10-31 2025-11-14 주식회사 삼양홀딩스 분말형 지혈제 조성물 및 이의 제조 방법
US20210228765A1 (en) * 2020-01-28 2021-07-29 Becton, Dickinson And Company Self-activating catheter insertion site dressing
JP6997890B2 (ja) * 2020-02-07 2022-01-18 花王株式会社 皮膚外用組成物
US11642288B2 (en) 2020-02-07 2023-05-09 Kao Corporation Skin external composition
CN114681659B (zh) * 2020-12-31 2023-04-18 广州迈普再生医学科技股份有限公司 复合止血粉及其制备方法和应用
CN114272445B (zh) * 2021-12-06 2023-02-03 盐城工学院 一种可用于体外和体内的止血防粘连材料及其制备方法

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517772A (en) * 1945-05-11 1950-08-08 Parke Davis & Co Neutralized oxidized cellulose products
US2914444A (en) * 1950-12-12 1959-11-24 David F Smith Cellulosic hemostatic composition
US2773000A (en) * 1952-06-06 1956-12-04 Johnson & Johnson Hemostatic surgical dressings
GB942305A (en) 1958-12-23 1963-11-20 Parachem Corp Improvements in or relating to antiseptic film and method and apparatus for producing the same
US3364200A (en) * 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
NL262878A (de) 1960-03-28
US3328259A (en) * 1964-01-08 1967-06-27 Parachem Corp Dressing for a wound containing a hemostatic agent and method of treating a wound
US3328529A (en) * 1964-08-31 1967-06-27 Heath Co Phase shifting circuit for fm stereo receiver
US3868955A (en) * 1973-10-05 1975-03-04 Personal Products Co Aldehyde polysaccharide dressings
US4289824A (en) * 1977-04-22 1981-09-15 Avtex Fibers Inc. High fluid-holding alloy rayon fiber mass
DE3037513C2 (de) * 1980-10-03 1983-05-05 Steffan, Wolfgang, 8425 Neustadt Kollagene Wundauflage
IN159332B (de) 1983-01-28 1987-05-02 Jai Mangal Sinha Thunuguntla
JPS6087225A (ja) 1983-10-18 1985-05-16 Unitika Ltd フイブリン形成促進材料の製造法
US4600574A (en) * 1984-03-21 1986-07-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of producing a tissue adhesive
US4626253A (en) 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
CS253042B1 (en) * 1985-09-25 1987-10-15 Maxmilian Mozisek Haemostatical material
ATE84961T1 (de) 1986-08-25 1993-02-15 Goodrich Co B F Wundverband und verfahren zu seiner herstellung.
US4840626A (en) * 1986-09-29 1989-06-20 Johnson & Johnson Patient Care, Inc. Heparin-containing adhesion prevention barrier and process
US4752466A (en) * 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
US5185179A (en) 1988-10-11 1993-02-09 Semiconductor Energy Laboratory Co., Ltd. Plasma processing method and products thereof
CA2004740A1 (en) 1988-12-07 1990-06-07 Cary Linsky Low molecular weight heparin, heparinoid and hexuronyl hexosaminoglycan sulfate containing adhesion prevention barrier and process
US5134229A (en) * 1990-01-12 1992-07-28 Johnson & Johnson Medical, Inc. Process for preparing a neutralized oxidized cellulose product and its method of use
CN1035803C (zh) 1990-07-24 1997-09-10 中国化工进出口总公司 可溶性止血织物
US5180398A (en) * 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
US6066773A (en) 1993-03-22 2000-05-23 E. R. Squibb & Sons, Inc. Thin film dressing with absorbent border
GB2280850B (en) 1993-07-28 1997-07-30 Johnson & Johnson Medical Absorbable composite materials for use in the treatment of periodontal disease
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
CA2175203A1 (en) * 1993-11-03 1995-05-11 Thaddeus P. Pruss Hemostatic patch
US5660854A (en) 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
WO1996040033A1 (en) 1995-06-07 1996-12-19 Clarion Pharmaceuticals Inc. Non-biological patch for hemostasis
JPH0951912A (ja) 1995-08-11 1997-02-25 Sekisui Plastics Co Ltd 吸収体
JP2791317B2 (ja) * 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
US5945319A (en) * 1996-04-25 1999-08-31 Medtronic, Inc. Periodate oxidative method for attachment of biomolecules to medical device surfaces
US5925552A (en) * 1996-04-25 1999-07-20 Medtronic, Inc. Method for attachment of biomolecules to medical devices surfaces
US5821343A (en) * 1996-04-25 1998-10-13 Medtronic Inc Oxidative method for attachment of biomolecules to surfaces of medical devices
US6500777B1 (en) * 1996-06-28 2002-12-31 Ethicon, Inc. Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
GB2314840B (en) 1996-06-28 2000-09-06 Johnson & Johnson Medical Oxidized oligosaccharides and pharmaceutical compositions
IN192791B (de) * 1996-06-28 2004-05-22 Johnson & Johnson Medical
GB2314842B (en) * 1996-06-28 2001-01-17 Johnson & Johnson Medical Collagen-oxidized regenerated cellulose complexes
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
IE980057A1 (en) 1997-01-30 2000-11-15 Alpenstock Holdings Ltd Haemostatic aerosol composition of polyanhydroglucuronic acid and its salts
US6306154B1 (en) * 1997-06-18 2001-10-23 Bhk Holding Hemostatic system for body cavities
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
ATE247990T1 (de) 1997-07-02 2003-09-15 Coloplast As Herstellungsmethode für ein faserfreies, poröses material
JP3114016B2 (ja) * 1998-05-15 2000-12-04 株式会社ホギメディカル 細胞接着促進効果を有する創傷止血材
US6261679B1 (en) * 1998-05-22 2001-07-17 Kimberly-Clark Worldwide, Inc. Fibrous absorbent material and methods of making the same
DE19851334C2 (de) * 1998-11-06 2000-09-28 Aventis Behring Gmbh Flexible Wundauflage auf Fibrinbasis und Verfahren zu ihrer Herstellung
GB2344519B (en) * 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
US6333029B1 (en) * 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US6306424B1 (en) * 1999-06-30 2001-10-23 Ethicon, Inc. Foam composite for the repair or regeneration of tissue
CA2384897A1 (en) 1999-09-18 2001-03-29 Path Tech Limited Separation method
ATE263858T1 (de) 1999-09-27 2004-04-15 Bhk Holding Ltd Absorbierender stoff
JP3576063B2 (ja) 2000-02-22 2004-10-13 株式会社ホギメディカル 凝固蛋白質を含む可溶性創傷治癒止血セルロース繊維とその製造方法
US6627785B1 (en) 2000-02-29 2003-09-30 Virginia Commwealth University Wound dressings with protease-lowering activity
JP2001340375A (ja) 2000-05-31 2001-12-11 Toyobo Co Ltd 創傷被覆材
DE60030892T2 (de) 2000-07-04 2007-04-19 Frohwitter, Bernhard Wundverband mit einem aktiven therapeutischen agens
JP2002052077A (ja) 2000-08-07 2002-02-19 Unitika Ltd 創傷被覆材及びその製造方法
CN1455659A (zh) 2000-09-12 2003-11-12 弗吉尼亚州立大学 高压出血的治疗
US6599323B2 (en) * 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
JP4104462B2 (ja) 2001-01-25 2008-06-18 ニコメド ファーマ エイエス コラーゲンスポンジを調製する方法、コラーゲンフォームの一部を抽出するための装置、および伸長したコラーゲンスポンジ
WO2003020191A1 (en) * 2001-09-04 2003-03-13 University Of Iowa Research Foundation Cellulose membranes for biodegradable scaffolds
US7252837B2 (en) * 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
GB2399289B (en) 2003-03-10 2006-03-08 Johnson & Johnson Medical Ltd Hydrocolloid materials for use in wound healing
RU2235539C1 (ru) 2003-04-25 2004-09-10 Филатов Владимир Николаевич Способ получения порошкообразного материала для остановки кровотечений

Also Published As

Publication number Publication date
JP2005015484A (ja) 2005-01-20
CN100384489C (zh) 2008-04-30
EP1493451A1 (de) 2005-01-05
US8709463B2 (en) 2014-04-29
US20040265371A1 (en) 2004-12-30
EP1493451B1 (de) 2010-09-15
JP4920177B2 (ja) 2012-04-18
CN1575821A (zh) 2005-02-09
ES2349775T3 (es) 2011-01-11
DE602004029118D1 (de) 2010-10-28
US20060233869A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
ATE481115T1 (de) Hämostatische vorrichtungen und zusammensetzungen aus oxidierter zellulosepartikel und ein polysaccharid bindemittel
EP1721623A3 (de) Absorbierende Polymerzusammensetzungen, medizinische Artikeln und Verfahren
EP1992676A4 (de) Organomolybdänadditiv, herstellung davon und schmiermittelzusammensetzung, die das additiv enthält, und verwendungen davon
EP4516358A3 (de) Il-15-konjugate und verwendungen davon
EP2338332A3 (de) Hohles Glukan- oder Zellenwand-Partikel, das eine Terpenkomponente verkapselt
DE69736888D1 (de) Verfahren und zusammensetzungen zur verbesserung der bioadhäsiven eigenschaften von polymeren
ATE520372T1 (de) Poröses implantat für den bandscheibennukleus- ersatz
ATE371442T1 (de) Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
DE60112527D1 (de) Vernetzersysteme aus Monohydroxyalkylharnstoff und Polysaccharid
LUC00065I1 (de)
AU2003303458A1 (en) Ampholytic copolymer and use thereof
EP2431385A3 (de) Kombinationstherapie mit Chlorotoxin
ATE445386T1 (de) Polymerische parfümpartikel
DE60234774D1 (de) Anorganische partikel und herstellungsverfahren
MY124876A (en) Biostatic filter
EP1531846A4 (de) Konjugate aus ligand, linker und zytotoxischem agens sowie verwandte zusammensetzungen und verwendungsverfahren
WO2003024499A3 (en) Water-soluble coating for bioactive devices
EP2468772A3 (de) EGFL7-Antikörper und Verwendungsverfahren
TW200605912A (en) Tooth-whitening compositions comprising silicone polymer and methods therefor
EP1521450A3 (de) System und Verfahren zur Erzeugung einer multidimensionalen Zitterstruktur und Anwendung
AU2003272778A1 (en) Nanostructured and nanoporous film compositions, structures, and methods for making the same
WO2003042273A8 (en) Compounds containing quaternary carbons, medical devices, and methods
IL171875A0 (en) Pioglitazone salts,such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
EP1920342A4 (de) Systeme, verfahren und vorrichtungen eines email-client

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties